目的:探讨应用丝裂霉素C的Ahmed青光眼阀植入联合全视网膜光凝治疗新生血管性青光眼的临床疗效。方法:新生血管性青光眼26例26眼,应用丝裂霉素C的Ahmed青光眼阀植入术联合全视网膜光凝治疗。结果:随访12mo,成功:16例眼压<21mmHg(61.54%),无明显眼部刺激症状。术前眼压平均49.78±14.17mmHg,术后眼压下降到平均18.45±8.91mmHg。末次复诊视力提高14眼(53.85%),视力不变12眼,无视力下降或丧失者。26眼中虹膜新生血管全部消退21眼,部分消退5眼。术后并发症主要有:浅前房6眼(23.08%),前房少量积血3眼(11.54%),引流管内口堵塞2眼(7.69%),引流盘纤维包裹1眼(3.85%)。结论:应用丝裂霉素C的Ahmed青光眼阀植入联合全视网膜光凝术治疗新生血管性青光眼,既能及时降低眼压,又能拯救或提高视力,是治疗新生血管性青光眼的一种安全而有效的方法。

AIM:To investigate the therapeutic effect of Ahmed glaucoma valve implantation with mitomycin C combined with retinal photocoagulation in treatment of neovascular glaucoma.METHODS:Twenty-six eyes with neovascular glaucoma were underwent the implantation of glaucoma valve combined with panretinal photocoagulation.RESULTS:Follow-up 12 months,the success rate was 61.54%.the average intraocular pressure decreased from 49.78±14.17mmHg preoperatively to 18.45±8.91mmHg postoperatively.In the postoperative ultimate check-up,visual acuity of 14 cases were improved(53.85%),12 cases had no change,No case was decreased and impairmented.The new vessels of the iris disappeared in 21 eyes.The important complications such as shallow anterior chamber was 6 in eyes(23.08%),hyphema 3 eyes(11.54%),tube occlusion 2 eyes(7.69%),fibrosis around Ahmed valve 1 eye(3.85%).CONCLUSION:Ahmed glaucoma valve implantation combined with panretinal photocoagulation in treatment of neovascular glaucoma can not only decreased intraocular pressure timely but also increased visual acuity.It is a safe and effective approach to those patients with neovascular glaucoma.

R779.6